Uniphar (LON:UPR) Reaches New 12-Month High - What's Next?

Uniphar plc (LON:UPR - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 240 ($3.18) and last traded at GBX 237 ($3.14), with a volume of 39509 shares. The stock had previously closed at GBX 235 ($3.11).

Analyst Upgrades and Downgrades

Separately, Shore Capital reissued a "buy" rating on shares of Uniphar in a research note on Tuesday, February 25th.

Uniphar Stock Up 0.9 %

The business has a 50 day simple moving average of GBX 221.78 and a 200-day simple moving average of GBX 197.96. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm has a market capitalization of £737.74 million, a price-to-earnings ratio of 16.48 and a beta of 0.75.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Shareholders of record on Thursday, April 24th will be issued a €0.01 ($0.01) dividend. This represents a yield of 0.47%. This is a positive change from Uniphar's previous dividend of $0.01. The ex-dividend date is Thursday, April 24th. Uniphar's payout ratio is presently 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.